72 results on '"Rengan, R."'
Search Results
2. Dosimetric Impact of Radiolucent Carbon Fiber Hardware for Post-Operative Spine Stereotactic Body Radiation Therapy
3. FLASH vs. Conventional Dose Rate Proton Radiation in Mouse Abdomen
4. Transition to Disease-Site Specific Chart Rounds: An Evaluation of Impact on Quality and Perceptions of Practitioners
5. O012 - FLASH Mechanisms Track (Oral Presentations) MOUSE ABDOMEN RADIATION USING A 50 MEV PROTON BEAM: FLASH VS. CONVENTIONAL DOSE RATE
6. DNA Damage Response Inhibitors as Potentiators of Radiation and Immunogenicity in Merkel Cell Carcinoma
7. Prognostic Value and Peripheral Immunologic Correlates of Early FDG PET Response Imaging in a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable NSCLC
8. Lessons Learned from Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients
9. Predicted Inferior Outcomes for Patients Treated with Lung SBRT on Systems Which Fail IROC-H Audits
10. Scanning Beam Proton Therapy Versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity and Outcomes
11. Upstaging in Repeat PET/CT prior to Chemoradiation in Locally Advanced NSCLC: Implications for Clinical Care
12. Early PET/CT Response Assessment for Selective FDG PET-Guided Dose Escalation in Locally Advanced NSCLC Patients Enrolled on the FLARE-RT Protocol
13. A Contour-Based Approach for Predicting Corneal Toxicity in Patients with Uveal Melanoma Treated with Proton Therapy
14. Late Rectal Bleeding in Patients with and Without Pre-Rectal Hydrogel Spacer During Proton Beam Therapy for Prostate Cancer
15. Long-term Results of a Phase I/II Trial of Nelfinavir with Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
16. Dose Comparison between Proton Pencil Beam and Monte Carlo Dose Calculation Algorithm in Lung Cancer Patients
17. A Strategy to Reduce Acute Toxicity from Twice Daily Chemoradiation Therapy for Limited-Stage Small-Cell Lung Cancer
18. Correlation of Perfused Lung Heterogeneity and Dosimetry With Incidence of Radiation Pneumonitis
19. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated with Proton Therapy on the Proton Collaborative Group Prospective Registry Trial
20. Four-Dimensional Computer Tomography Scans for Conformal Thoracic Treatment Planning: Is a Single Scan Sufficient to Capture Thoracic Tumor Motion?
21. Clinical Impact of Spatial Variations in Proton Relative Biological Effectiveness (RBE) Among Patients Receiving Radiation to the Prostate and Thorax
22. Prospective Assessment of Demographic Characteristics Associated With Worse Health-Related Quality of Life Measures Following Definitive Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer
23. Central Volume Target Overlap and Esophageal Dose Predict for Toxicity in a Prospective Study of Reirradiation for Non-Small Cell Lung Carcinoma Using Proton Therapy
24. CTV-based Robustness Optimization Versus PTV-based Conventional Optimization for Intensity Modulated Proton Therapy Planning
25. First Clinical Report of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Postoperative Radiation Therapy for Non-Small Cell Lung Cancer
26. Correlation of Perfusion and Ventilation SPECT/CT to Incidence of Grade 2+ Radiation Pneumonitis
27. Relationship Between Cardiac Radiation Dose and Extent / Location of Mediastinal Lymph Node Involvement in Stage III NSCLC Patients
28. Heart Dose and Outcomes in Radiation Treatment for Esophageal Cancer
29. Response, Resistance Mechanisms, and Biomarkers for Radiation and Immune Checkpoint Blockade
30. Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions: Metastatic Non-Small Cell Lung Cancer
31. Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) Reirradiation for New or Recurrent Pulmonary Malignancies Following Previous In-Field Conventionally Fractionated Thoracic Radiation Therapy (CFRT): Locally Advanced Non-Small Cell Lung Cancer
32. Stereotactic Body Radiation Therapy (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC): Outcomes by Fractionation, Tumor Stage and Location, and Patient Operability: Early-Stage Non-Small Cell Lung Cancer
33. Evaluation of Treatment Plan Robustness With Adaptive Re-planning for Recurrent Lung Cancer Patients Treated With Protons
34. Stereotactic Body Radiation Therapy (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC): Outcomes by Fractionation, Tumor Stage and Location, and Patient Operability
35. Anatomic Variations in Pulmonary Perfusion and Ventilation Per Quantitative MAA and DTPA SPECT/CT in Patients Receiving Thoracic Radiation Therapy
36. Impact of Functional Lung Imaging Using Ventilation/Perfusion SPECT/CT on Planning Objectives in Thoracic Radiation Therapy
37. Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial?: A Multi-institutional Propensity-Score Matched Analysis
38. Is Overall Treatment Time a Predictive Factor in Radiation Therapy for Non-Small Cell Lung Cancer?
39. Negative Correlation Between Quantitative FDG PET/CT and MAA SPECT/CT Blood Perfusion Imaging Parameters in Thoracic Malignancy Patients
40. Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions
41. Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) Reirradiation for New or Recurrent Pulmonary Malignancies Following Previous In-Field Conventionally Fractionated Thoracic Radiation Therapy (CFRT)
42. Development of a Multi parametric Cost-Effectiveness Model for Comparison of Therapeutic Modalities in Definitive Radiation Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)
43. High BMI Associated With Worse Quality of Life in Breast Cancer Patients Receiving Radiation Therapy
44. Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer
45. Evolution of and Predictors for Pulmonary Fibrosis Following Definitive Thoracic Radiation Therapy
46. Comparison of Intensity Modulated Radiation Therapy, Adaptive Radiation Therapy, Proton Radiation Therapy, and Adaptive Proton Radiation Therapy for Small Cell Lung Cancer
47. Phase I Randomized Trial of Dietary Flaxseed in Non-small Cell Lung Cancer Patients Receiving Chemoradiation
48. An Analysis of Survival After Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer
49. The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Prior to Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer
50. Feasibility of Proton Therapy for Elective Nodal Irradiation in Patients With Locally Advanced Non-small Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.